Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell Transplantation (HCT) Using HLA Class I or Class II Antigen Mismatched Donors: Results from a Phase II Multi-Center Trial

Brian Kornblit, MD PhD, Barry Storer, Michael B. Maris, MD, Niels Smedegaard Andersen, MD PhD, Thomas R. Chauncey, MD PhD, Effie W. Petersdorf, MD, Ann Woolfrey, MD, David G. Maloney, MD PhD, Rainer Storb, MD, Brenda M Sandmaier, MD

Blood (2019) 134 (Supplement_1): 369.

https://doi.org/10.1182/blood-2019-123196

Published: 2019

Journal Articles

From Bone Marrow to Mobilized Peripheral Blood Stem Cells: The Circuitous Path to Clinical Gene Therapy for Fanconi Anemia

Pamela S Becker, MD PhD, Jennifer Adair, PhD, Grace Choi, BS, Anne Lee, Ann Woolfrey, MD, Lauri S Burroughs, MD, Kanwaldeep K. Mallhi, MD, Amy E. Geddis, MD PhD, Hans-Peter Kiem, MD PhD

Blood (2018) 132 (Supplement 1): 2208.

https://doi.org/10.1182/blood-2018-99-120278

Published: 2018

Journal Articles

Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival

Blood (2017) 130 (Supplement 1): 848.

https://doi.org/10.1182/blood.V130.Suppl_1.848.848

Published: 2017

Journal Articles

Novel Lineage Depletion and Manufacturing Allows for Unprecedented Preservation of Autologous Blood Stem Cells for Gene Therapy of Fanconi Anemia Complementation Group Α

Jennifer Adair, PhD, Devikha Chandrasekaran, MS, Stefanie Schmuck, BS, Gabriella Sghia-Hughes, BS, Grace Choi, BS, Anne Lee, BS, Kevin G Haworth, BS, PhD, Ann Woolfrey, MD, Lauri S Burroughs, MD, Pamela S. Becker, MD PhD, Hans-Peter Kiem, MD PhD

Blood (2017) 130 (Supplement 1): 2451.

https://doi.org/10.1182/blood.V130.Suppl_1.2451.2451

Published: 2017

Journal Articles

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Blood (2012) 120 (21): 467.

https://doi.org/10.1182/blood.V120.21.467.467

Published: 2012

Journal Articles

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Brian McClune, DO, Tanya L. Pedersen, MPH, Kwang W Ahn, PhD, Erica D Warlick, MD, Joseph Pidala, MD, MS, Edmund K Waller, MD PhD, J. Douglas Rizzo, MD MS, Mitchell S. Cairo, MD, Ann Woolfrey, MD, Andrew Artz, MD MS, Hillard M. Lazarus, MD FACP, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 1015.

https://doi.org/10.1182/blood.V118.21.1015.1015

Published: 2011

Journal Articles

Increased Incidence of Chronic Graft-Versus-Host Disease (GVHD) and No Survival Advantage with Filgrastim-Mobilized Peripheral Blood Stem Cells (PBSC) Compared to Bone Marrow (BM) Transplants From Unrelated Donors: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0201, a Phase III, Prospective, Randomized Trial

Blood (2011) 118 (21): 1.

https://doi.org/10.1182/blood.V118.21.1.1

Published: 2011

Journal Articles

Larger Numbers of Donor Naïve CD8+ T-Cells and Plasmacytoid Dendritic Cell Precursors In Allogeneic BM Grafts From Unrelated Donors Are Associated with Improved Survival: Results From BMT CTN 0201

Edmund K Waller, MD PhD, Wayne A.C. Harris, Steven Devine, David L. Porter, MD, Shin Mineishi, MD, John M. McCarty, MD, Corina E Gonzalez, MD, Thomas R Spitzer, MD, Oleg I. Krijanovski, PhD, MD, Michael L. Linenberger, MD, Ann Woolfrey, MD, Alan Howard, PhD, Cathy Gurgol, Brent R. Logan, PhD, Dennis L Confer, MD, Claudio Anasetti, MD

Blood (2011) 118 (21): 1004.

https://doi.org/10.1182/blood.V118.21.1004.1004

Published: 2011

Journal Articles

RESULTS of Allogeneic TRANSPLANTATION for Polycythemia VERA and Essential Thrombocythemia

Karen K Ballen, MD, Mukta Arora, MD, Xiaochun Zhu, MS, Manza Agovi, Matt Kalaycio, MD, Richard T Maziarz, MD, Jorge E. Cortes, MD, Ann Woolfrey, MD, Mary M. Horowitz, MD, MS, Wael Saber, MD, MS

Blood (2010) 116 (21): 3514.

https://doi.org/10.1182/blood.V116.21.3514.3514

Published: 2010

Journal Articles

Reduced Intensity Conditioning (RIC) Transplantation In Acute Leukemia: The Effect of Source of Unrelated Donor Stem Cells on Outcomes

Claudio Brunstein, MD, Mary Eapen, MBBS, Kwang w Ahn, PhD, Frederick R. Appelbaum, MD, Karen K Ballen, MD, Richard Champlin, Fangyu Kan, MS, Mary J. Laughlin, MD, Robert J Soiffer, MD, Daniel J. Weisdorf, MD, Ann Woolfrey, MD, Mary M. Horowitz, MD, MS, John E. Wagner, MD

Blood (2010) 116 (21): 908.

https://doi.org/10.1182/blood.V116.21.908.908

Published: 2010

Journal Articles

A Randomized 3-Arm Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute Graft-Versus-Host Disease (GVHD) After Unrelated Donor Hematopoietic Cell Transplantation (HCT) Using Nonmyeloablative Conditioning for Patients with Hematologic Malignancies: A Multi-Center Trial.

Brenda M. Sandmaier, MD, Michael Maris, MD, Barry Storer, PhD, Lars Vindelov, MD, Amelia Langston, MD, James C. Wade, MD, MPH, Wolfgang A. Bethge, MD, Michael Pulsipher, MD, Thoralf Lange, MD, Thomas Chauncey, MD, Finn Petersen, MD, Kai Hübel, MD, Ann Woolfrey, MD, Mary E.D. Flowers, MD, David G. Maloney, MD, PhD, Rainer F. Storb, MD

Blood (2009) 114 (22): 348.

https://doi.org/10.1182/blood.V114.22.348.348

Published: 2009

Journal Articles

Outcome of Hematopoietic Cell Transplant from HLA-Matched Siblings Compared to a Volunteer Unrelated Donors Matched for HLA-A, B, C, DRB1, and DQB1 Alleles.

Ann Woolfrey, MD, Theodore Gooley, PhD, Mari Malkki, John A. Hansen, MD, Paul J. Martin, MD, Stephanie J. Lee, MD, Frederick R. Appelbaum, MD, John M. Pagel, MD, Effie W. Petersdorf, MD

Blood (2007) 110 (11): 170.

https://doi.org/10.1182/blood.V110.11.170.170

Published: 2007

Journal Articles

Risk Factors Analyses for Outcomes after Unrelated Cord Blood Transplantation for Children with Myelodysplastic Syndromes. An Analysis on Behalf of EWOG-MDS and Eurocord Groups.

Adrienne B. Moreno-Madureira, MD, Pierre Teira, MD, Franco Locatelli, MD, PhD, Alessandra Piccardi, MD, Ann Woolfrey, MD, Ka-Wah Chan, MD, Gérard Socié, MD, PhD, Ajay J. Vora, MD, Yves Bertrand, MD, Carmem Bonfim, MD, Federico Garnier, MD, Irina Ionescu, MD, Eliane Gluckman, MD, PhD, Charlotte M. Niemeyer, MD, PhD, Vanderson Rocha, MD, PhD

Blood (2007) 110 (11): 2022.

https://doi.org/10.1182/blood.V110.11.2022.2022

Published: 2007

Journal Articles

Outcome Following Hematopoietic Cell Transplantation for Patients with AML-CR1: Comparison between Matched-Sibling and Unrelated Allografts.

John M. Pagel, MD, PhD, Ted Gooley, PhD, Effie W. Petersdorf, MD, PhD, Mari Malkki, PhD, Lacey Drouet, Ann Woolfrey, MD, John A. Hansen, MD, Frederick R. Appelbaum, MD

Blood (2007) 110 (11): 330.

https://doi.org/10.1182/blood.V110.11.330.330

Published: 2007

Journal Articles

Impact of Prior Therapy with Imatinib Mesylate on the Outcome of Hematopoietic Cell Transplantation (HCT) for Chronic Myeloiod Leukemia (CML).

Stephanie Lee, MD, Richard Maziarz, MD, Manisha Kukreja, MBBS, MPH, Tao Wang, PhD, Sergio Giralt, MD, Jeffrey Szer, MBBS, Ann Woolfrey, MD, Mukta Arora, MD, MS

Blood (2007) 110 (11): 738.

https://doi.org/10.1182/blood.V110.11.738.738

Published: 2007

Journal Articles

Postgrafting Immune Suppression Combined with Nonmyeloablative Conditioning for Transplantation of HLA-Identical Hematopoietic Cell Grafts: Results of a Phase I Study for Treatment of Immunodeficiency Disorders.

Lauri Burroughs, MD, Rainer F. Storb, MD, Wendy Leisenring, Michael Pulsipher, MD, Michael R. Loken, PhD, Troy Torgerson, MD, Hans D. Ochs, MD, Ann Woolfrey, MD

Blood (2005) 106 (11): 327.

https://doi.org/10.1182/blood.V106.11.327.327

Published: 2005

Journal Articles

A Prospective Study of G-CSF Primed Bone Marrow from Pediatric Donors as a Stem Cell Source for Allogeneic Bone Marrow Transplant: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study.

Haydar Frangoul, MD, Ann Woolfrey, MD, Shakila Khan, MD, Michael Pulsipher, MD, John Levine, MD, David Baker, MD, Mark Walters, MD, Mouhab Ayas, MD, Yaddanapudi Ravindranath, MD, Stephan Grupp, MD, PhD, Dean Billheimer, PhD, Eneida Nemecek, MD

Blood (2005) 106 (11): 1964.

https://doi.org/10.1182/blood.V106.11.1964.1964

Published: 2005

Journal Articles

Prognostic Relevance of “Early-Onset” Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation.

Marco Mielcarek, MD, Lauri Burroughs, MD, Wendy Leisenring, PhD, Paul Martin, MD, Razvan Diaconezcu, MD, Brenda Sandmaier, MD, David Maloney, MD, PhD, Thomas Chauncey, MD, PhD, Michael Maris, MD, Judith Shizuru, MD, Karl Blume, MD, Ute Hegenbart, MD, Dietger Niederwieser, MD, Stephen Forman, MD, Benedetto Bruno, MD, Ann Woolfrey, MD, Rainer Storb, MD

Blood (2004) 104 (11): 423.

https://doi.org/10.1182/blood.V104.11.423.423

Published: 2004

NARROW

Sirolimus Combined with Cyclosporine (CSP) and Mycophenolate Mofetil (MMF) As Graft-Vs-Host Disease (GVHD) Prophylaxis after Nonmyeloablative (NMA) Hematopoietic Cell Transplantation (HCT) Using HLA Class I or Class II Antigen Mismatched Donors: Results from a Phase II Multi-Center Trial

From Bone Marrow to Mobilized Peripheral Blood Stem Cells: The Circuitous Path to Clinical Gene Therapy for Fanconi Anemia

Analysis of 10,462 8/8 HLA- Matched Unrelated Donor Transplants Could Not Identify a Donor Selection Score, As Younger Age Is the Only Significant Donor Characteristic Associated with Survival

Novel Lineage Depletion and Manufacturing Allows for Unprecedented Preservation of Autologous Blood Stem Cells for Gene Therapy of Fanconi Anemia Complementation Group Α

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Larger Numbers of Donor Naïve CD8+ T-Cells and Plasmacytoid Dendritic Cell Precursors In Allogeneic BM Grafts From Unrelated Donors Are Associated with Improved Survival: Results From BMT CTN 0201

RESULTS of Allogeneic TRANSPLANTATION for Polycythemia VERA and Essential Thrombocythemia

Reduced Intensity Conditioning (RIC) Transplantation In Acute Leukemia: The Effect of Source of Unrelated Donor Stem Cells on Outcomes

Outcome of Hematopoietic Cell Transplant from HLA-Matched Siblings Compared to a Volunteer Unrelated Donors Matched for HLA-A, B, C, DRB1, and DQB1 Alleles.

Risk Factors Analyses for Outcomes after Unrelated Cord Blood Transplantation for Children with Myelodysplastic Syndromes. An Analysis on Behalf of EWOG-MDS and Eurocord Groups.

Outcome Following Hematopoietic Cell Transplantation for Patients with AML-CR1: Comparison between Matched-Sibling and Unrelated Allografts.

Impact of Prior Therapy with Imatinib Mesylate on the Outcome of Hematopoietic Cell Transplantation (HCT) for Chronic Myeloiod Leukemia (CML).

Postgrafting Immune Suppression Combined with Nonmyeloablative Conditioning for Transplantation of HLA-Identical Hematopoietic Cell Grafts: Results of a Phase I Study for Treatment of Immunodeficiency Disorders.

A Prospective Study of G-CSF Primed Bone Marrow from Pediatric Donors as a Stem Cell Source for Allogeneic Bone Marrow Transplant: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study.

Prognostic Relevance of “Early-Onset” Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only